Triveni Bio
Drug DiscoveryWebsite
Developer of a clinical-stage biotechnology company designed to create antibody-based therapies targeting immunological and inflammatory diseases. The company offers a genetics-informed antibody disco...
Valuation
$310M
Market implied
Share Price
N/A
Total Raised
$231.6M
Last Round
Later Stage VC (Series B)
Jun 2025
Latest Funding Round
Later Stage VC (Series B)
Jun 18, 2025
$115M
raised
Investors
+12 other investors